Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
dc.identifier.other
WOS:000491295504209
dc.description.volume
dc.description.issue
Publisher
OXFORD UNIV PRESS
DOI
Abstract
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, SEP 27-OCT 01, 2019